The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Peptide Synthesis Market Size: A Thriving Landscape

• The peptide synthesis market has witnessed robust growth in recent years.
• From $5.22 billion in 2023, it is projected to reach $5.69 billion in 2024, boasting a CAGR of 8.9%.

Driving Forces Behind Market Growth

• Rise in peptide-based vaccines
• Growth in biotechnology and biopharmaceuticals
• Demand for high-purity peptides
• Regulatory approvals and standardization

Future Outlook: A Promising Growth Horizon

• Expectations soar for the market’s expansion, reaching $8.05 billion by 2028, with a CAGR of 9.1%.
• Factors fueling this growth include therapeutic peptides and customized peptide demands.
• Peptides’ vital role in drug discovery and development augurs well for market prospects.

Major Trends Shaping the Future

• Development of peptide mimetics
• Adoption of novel amino acid derivatives
• Advancements in solid-phase peptide synthesis (SPPs)
• Utilization of click chemistry

View More On The Real-Time PCR, Digital PCR And End-Point PCR Market Report 2024 – https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

Rising Incidence of Chronic Diseases Boosts Growth in the Peptide Synthesis Market

Addressing the Challenge of Chronic Diseases

• Peptide synthesis emerges as a critical tool in combating chronic diseases.
• Peptides exhibit anti-inflammatory and antioxidant properties, aiding in disease prevention.
• Targeting specific cellular processes and signaling pathways offers new therapeutic avenues.

Real-world Impact: The Case of Coronary Heart Disease

• Statistics reveal a surge in deaths due to coronary heart disease, underscoring the urgency for solutions.
• The UK witnessed a rise in deaths to 65,579 in 2021, compared to 64,170 in 2020.

Key Players Driving Innovation

• Thermo Fisher Scientific
• Novo Nordisk A/S
• Merck KGaA
• Lonza Group
• Kaneka Corporation

Advancing Next-Generation Peptide Synthesizers to Gain a Competitive Edge

The Quest for Innovation

• Industry leaders focus on developing next-gen peptide synthesizers.
• Products like PurePep Sonata+ offer enhanced efficiency, speed, and accuracy.
• Real-time flow technology ensures precise fluid transfers, elevating synthesis capabilities.

Market Movers: Key Developments

• Gyros Protein Technologies introduces PurePep Sonata+ in March 2022.
• The system integrates real-time flow technology for optimal performance.

Swiss Company Biosynth Acquires UK-Based Cambridge Research Biochemicals to Strengthen Peptide Division

Strategic Acquisitions for Market Expansion

• Biosynth International, Inc., acquires Cambridge Research Biochemicals, bolstering its peptide division.
• CRB’s expertise in complex peptide chemistry and fluorescent dye labeling adds value to Biosynth’s portfolio.

Segmentation Insights: Navigating Market Dynamics

1. By Product and Service: Reagents, Equipment, Services
2. By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid and Recombinant Technology
3. By End User: Pharmaceutical and Biotechnology Companies, Contract Manufacturing and Development Organizations (CDMOs) and Contract Research Organizations (CROs), Academic and Research Institutes

Regional Dynamics: North America Leads, Asia-Pacific Surges

• North America dominated the peptide synthesis market in 2023.
• Asia-Pacific emerges as the fastest-growing region in the forecast period.

As the peptide synthesis market continues its upward trajectory, fueled by innovation, strategic partnerships, and growing demand, it heralds a promising future in combating chronic diseases and advancing therapeutic interventions. With key players spearheading advancements and global regions embracing this technology, the landscape is ripe for transformative growth.

Request A Sample Of The Global Real-Time PCR, Digital PCR And End-Point PCR Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13296&type=smp